Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GRWG GrowGen 2.84 had a spike in volume last week and continues today.
http://www.otcmarkets.com/stock/GRWG/profile
GrowGeneration Reports Record 3rd Quarter Revenue
Q3 Revenue up 86% to $ 4.0 million; Same-Store Sales increase 31%
PR Newswire
DENVER, Nov. 8, 2017
DENVER, Nov. 8, 2017 /PRNewswire/ -- GrowGeneration Corp. (OTCQX: GRWG), ("GrowGen" or the "Company") one of the largest specialty retail hydroponic and organic gardening stores, selling to both the commercial and home cannabis markets, with currently 14 locations, today reported financial results for its 3rd quarter ended September 30, 2017.
https://www.otcmarkets.com/stock/GRWG/news/GrowGeneration-Reports-Record-3rd-Quarter-Revenue?id=174626&b=y
GRWG Grow Generation
http://www.growgeneration.com/investors.html
Investor Dashboard
https://www.newcannabisventures.com/growgeneration-corp-stock-grwg-investor-dashboard/
$GRWG 2.43 +0.330 (+15.71%) Vol 255,804..Avg.Volume 10d 36,209/per Etrade
Share Statistics
Avg Vol (3 month) 25.53k
Avg Vol (10 day) 49.13k
Shares Outstanding 16.44M
Float 9.35M
% Held by Insiders 32.30%
Per yahoo
https://finance.yahoo.com/quote/GRWG/key-statistics?p=GRWG
Note above: yahoo has not updated income from Q3 ending September?
GrowGeneration reported its Q3 results earlier this month, with YTD sales of $10.7mm, representing growth of 91% (43% on same-store basis). Learn more about this hydroponics store operator with locations in California, Colorado, Nevada and Washington by visiting the company's Investor Dashboard.
GrowGeneration Corp Stock (OTCQX: GRWG) - Investor Dashboard
https://www.newcannabisventures.com/growgeneration-corp-stock-grwg-investor-dashboard/
$GRWG $KSHB $MXPEF $SPRWF accumulated a few #MJ stocks over the passed year MXPEF being the most recent purchase.
Growgeneration Corp.GRWG OTCQX U.S Investor Presentation November 2017
https://growgeneration.com/static/img/grwg-investor-presentation-2017-nov.pdf
http://www.growgeneration.com/
https://www.otcmarkets.com/stock/GRWG/profile
KUSH BOTTLES INC. KSHB: OTCQB 2.91 +0.11 (+3.93%)
Nov. 28. 2017
Fiscal Year End 2017 Financial Summary
Revenue was up 129% Year-over-Year to $18.8 million; revenues included four months of sales from CMP Wellness which was acquired on May 1, 2017.
Gross margins held steady at 33%, in line with the prior year period.
Net income, including $943,000 in non-cash stock compensation, $301,000 in depreciation and amortization expense and $4.6 million in SG&A, was $69,000 compared to net income of $72,000 in fiscal year 2016; the increase in operating expenses stems from costs associated with the acquisition of CMP Wellness, as well as higher SG&A costs to support an expanded outside sales program.
Working capital was $3.45 million compared to $2.03 million at August 31, 2016.
https://ir.kushbottles.com/category/press-releases/
https://www.kushbottles.com
https://www.otcmarkets.com/stock/KSHB/profile
MPX Bioceutical Corporation CSE:MPX OTCQB:MPXEF
Note: Recent Name Change to MPX
https://www.otcmarkets.com/stock/MPXEF/news
Ohio Receives 370 Applications for up to 60 Medical Cannabis Dispensary Licenses
https://www.newcannabisventures.com/ohio-receives-370-applications-for-up-to-60-medical-cannabis-dispensary-licenses/
Shareholder Reports Updated Equity Interest in MPX Bioceutical Corporation..and filings on SEDAR
http://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00007716
Reports Q1 Fiscal 2018 Results
Total revenues of $5.1 million, consisting of:
- Health for Life dispensary sales of dried flower and concentrates of $3.6M
https://www.otcmarkets.com/stock/MPXEF/news/BCC-Reports-Q1-Fiscal-2018-Results?id=171187&b=y
Website: http://mpxbioceutical.com
Management-Presentation_27-October-2017
http://canadianbioceutical.com/wp-content/uploads/Management-Presentation_27-October-2017-web.pdf
Supreme Pharmaceuticals (OTC:SPRWF) (TSXV:FIRE)
...wholly owned 7ACRES subsidiary recently received approval from Health Canada to begin cultivation at its 30,000 square-foot flowering rooms at the company's hybrid grow facility. The additional flowering rooms increases the size of 7ACRES' flowering facility to 40,000 square feet. 7ACRES, and thus Supreme, also has its footing in oils via a retail partnership with Aurora Cannabis (TSX: ACB) (OTC: ACBFF). In its fourth-quarter financial results, Aurora said sales of dried medical cannabis and cannabis oils contributed $5.6 million to revenues, of which $0.4 million (7.1%) was generated in Germany and $5.2 million in Canada (http://nnw.fm/MOgY2).
Adoption of cannabis oil continues to increase as a preferred alternative to cannabinoid consumption, providing cannabis cultivators with an unprecedented market opportunity paced by rising consumer demand.
https://www.networknewswire.com/rising-demand-cannabis-oils-pushes-canadas-producers-overdrive/
Supreme Commences Production in New Flowering Rooms
November 07, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Commences-Production-in-New-Flowering-Rooms/default.aspx
Supreme Crosses Important Revenue Milestone
October 03, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Crosses-Important-Revenue-Milestone/default.aspx
Supreme Completes First Sales with Aurora Cannabis
September 05, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Completes-First-Sales-with-Aurora-Cannabis-/default.aspx
more
http://www.supreme.ca/investors/overview/default.aspx
Filings on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
$SPRWF 1.56 Moving on Friday's News...#Cannabis
SUPREME SIGNS HIGH-QUALITY FLOWER SUPPLY LOI AGREEMENT WITH ABLE BC.
http://www.supreme.ca/news/press-release-details/2017/Supreme-signs-High-Quality-Flower-supply-LOI-agreement-with-ABLE-BC/default.aspx
The Alliance of Beverage Licensees (ABLE BC)
https://ablebc.ca
B.C.’s liquor stores are the responsible way to retail #cannabis $SPRWF
http://vancouversun.com/opinion/op-ed/opinion-b-c-s-liquor-stores-are-the-responsible-way-to-retail-cannabis
Website: Supreme Pharmaceuticals
http://www.supreme.ca/investors/overview/default.aspx
Filings: on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
https://twitter.com/supremepharma
Supreme Pharmaceuticals Inc—Producing Craft Quality Cannabis at Commercial Scale
Overview
Supreme Pharmaceuticals Inc (TSXV:FIRE) is a licensed producer uniquely implementing B2B cannabis sales within Canada. Based in Ontario, the company is headed in Toronto and their sole asset, 7ACRES, is situated in Kincardine, on the southern shores of Lake Huron. Supreme Pharmaceuticals’ mission is to lead the cannabis industry, innovate and keep pushing cannabis forward while remaining focused on the quality of the product.
The first to adopt a licensed B2B wholesale model in Canada, Supreme Pharmaceuticals’ approach is based on producing high-quality cannabis that can be sold at a commercial scale to licensed producers, value-add manufacturers, storefronts and more. The goal of this approach is to allow for specialization across the industry, allowing partners to develop and succeed while they are supplied with quality cannabis.
To this effect, once they obtained their license to sell from their 7ACRES property in June 2017, Supreme Pharmaceutical entered into sale partnerships in September with two licensed producers, Aurora Cannabis (TSXV:ACB) and Emerald Health Botanicals, a subsidiary of Emerald Health Therapeutics (TSXV:EMH).
The 7ACRES property is on its way to becoming the country’s leading producer of high-quality commercial cannabis at a scale that has not yet been seen. Currently cultivating on 16,500 square feet, Supreme expects to have the entire 342,000-square-foot hybrid greenhouse facility running at full capacity by 2019 with a projected 50,000 kilograms of cannabis produced per year and $200 million to $400 million in revenue per year.
Supreme’s management team is one with vast amounts of experience in the cannabis and financial sectors. The team is headed by John Fowler, a lawyer that has been an advocate for the cannabis industry and thus has deep knowledge of both the medicinal and recreational spaces.
Investment Highlights
Innovative wholesale business model for bulk cannabis sales to strategic partners
Low operational costs to produce high-quality product
License to sell received in June 2017
Partnerships for cannabis sales with Aurora Cannabis and Emerald Health Botanicals
First reported quarter of sales to be reported by end of 2017
Well-funded with over $70 million raised collectively in 2016 and 2017
2016 private placement of $55 million from a syndicate of four banks led by Canaccord Genuity Corp
7ACRES property with 342,000 square-foot hybrid greenhouse facility
Expecting to run at full capacity in 2019 producing 50,000 kg per annum
Strong management team with notable experience in the cannabis space
More
https://investingnews.com/company-profiles/cannabis-wholesale-commercial-scale-producing-craft-quality-7acres/
$SPRWF 1.57 Moving on Friday's News...
SUPREME SIGNS HIGH-QUALITY FLOWER SUPPLY LOI AGREEMENT WITH ABLE BC.
http://www.supreme.ca/news/press-release-details/2017/Supreme-signs-High-Quality-Flower-supply-LOI-agreement-with-ABLE-BC/default.aspx
The Alliance of Beverage Licensees (ABLE BC)
https://ablebc.ca
B.C.’s liquor stores are the responsible way to retail #cannabis $SPRWF
http://vancouversun.com/opinion/op-ed/opinion-b-c-s-liquor-stores-are-the-responsible-way-to-retail-cannabis
Website: Supreme Pharmaceuticals
http://www.supreme.ca/investors/overview/default.aspx
Filings: on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
https://twitter.com/supremepharma
Supreme Pharmaceuticals Inc—Producing Craft Quality Cannabis at Commercial Scale
Overview
Supreme Pharmaceuticals Inc (TSXV:FIRE) is a licensed producer uniquely implementing B2B cannabis sales within Canada. Based in Ontario, the company is headed in Toronto and their sole asset, 7ACRES, is situated in Kincardine, on the southern shores of Lake Huron. Supreme Pharmaceuticals’ mission is to lead the cannabis industry, innovate and keep pushing cannabis forward while remaining focused on the quality of the product.
The first to adopt a licensed B2B wholesale model in Canada, Supreme Pharmaceuticals’ approach is based on producing high-quality cannabis that can be sold at a commercial scale to licensed producers, value-add manufacturers, storefronts and more. The goal of this approach is to allow for specialization across the industry, allowing partners to develop and succeed while they are supplied with quality cannabis.
To this effect, once they obtained their license to sell from their 7ACRES property in June 2017, Supreme Pharmaceutical entered into sale partnerships in September with two licensed producers, Aurora Cannabis (TSXV:ACB) and Emerald Health Botanicals, a subsidiary of Emerald Health Therapeutics (TSXV:EMH).
The 7ACRES property is on its way to becoming the country’s leading producer of high-quality commercial cannabis at a scale that has not yet been seen. Currently cultivating on 16,500 square feet, Supreme expects to have the entire 342,000-square-foot hybrid greenhouse facility running at full capacity by 2019 with a projected 50,000 kilograms of cannabis produced per year and $200 million to $400 million in revenue per year.
Supreme’s management team is one with vast amounts of experience in the cannabis and financial sectors. The team is headed by John Fowler, a lawyer that has been an advocate for the cannabis industry and thus has deep knowledge of both the medicinal and recreational spaces.
Investment Highlights
Innovative wholesale business model for bulk cannabis sales to strategic partners
Low operational costs to produce high-quality product
License to sell received in June 2017
Partnerships for cannabis sales with Aurora Cannabis and Emerald Health Botanicals
First reported quarter of sales to be reported by end of 2017
Well-funded with over $70 million raised collectively in 2016 and 2017
2016 private placement of $55 million from a syndicate of four banks led by Canaccord Genuity Corp
7ACRES property with 342,000 square-foot hybrid greenhouse facility
Expecting to run at full capacity in 2019 producing 50,000 kg per annum
Strong management team with notable experience in the cannabis space
More
https://investingnews.com/company-profiles/cannabis-wholesale-commercial-scale-producing-craft-quality-7acres/
$SPRWF 1.57 Moving on Friday's News...
SUPREME SIGNS HIGH-QUALITY FLOWER SUPPLY LOI AGREEMENT WITH ABLE BC.
http://www.supreme.ca/news/press-release-details/2017/Supreme-signs-High-Quality-Flower-supply-LOI-agreement-with-ABLE-BC/default.aspx
The Alliance of Beverage Licensees (ABLE BC)
https://ablebc.ca
B.C.’s liquor stores are the responsible way to retail #cannabis $SPRWF
http://vancouversun.com/opinion/op-ed/opinion-b-c-s-liquor-stores-are-the-responsible-way-to-retail-cannabis
Website: Supreme Pharmaceuticals
http://www.supreme.ca/investors/overview/default.aspx
Filings: on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
https://twitter.com/supremepharma
Supreme Pharmaceuticals Inc—Producing Craft Quality Cannabis at Commercial Scale
Overview
Supreme Pharmaceuticals Inc (TSXV:FIRE) is a licensed producer uniquely implementing B2B cannabis sales within Canada. Based in Ontario, the company is headed in Toronto and their sole asset, 7ACRES, is situated in Kincardine, on the southern shores of Lake Huron. Supreme Pharmaceuticals’ mission is to lead the cannabis industry, innovate and keep pushing cannabis forward while remaining focused on the quality of the product.
The first to adopt a licensed B2B wholesale model in Canada, Supreme Pharmaceuticals’ approach is based on producing high-quality cannabis that can be sold at a commercial scale to licensed producers, value-add manufacturers, storefronts and more. The goal of this approach is to allow for specialization across the industry, allowing partners to develop and succeed while they are supplied with quality cannabis.
To this effect, once they obtained their license to sell from their 7ACRES property in June 2017, Supreme Pharmaceutical entered into sale partnerships in September with two licensed producers, Aurora Cannabis (TSXV:ACB) and Emerald Health Botanicals, a subsidiary of Emerald Health Therapeutics (TSXV:EMH).
The 7ACRES property is on its way to becoming the country’s leading producer of high-quality commercial cannabis at a scale that has not yet been seen. Currently cultivating on 16,500 square feet, Supreme expects to have the entire 342,000-square-foot hybrid greenhouse facility running at full capacity by 2019 with a projected 50,000 kilograms of cannabis produced per year and $200 million to $400 million in revenue per year.
Supreme’s management team is one with vast amounts of experience in the cannabis and financial sectors. The team is headed by John Fowler, a lawyer that has been an advocate for the cannabis industry and thus has deep knowledge of both the medicinal and recreational spaces.
Investment Highlights
Innovative wholesale business model for bulk cannabis sales to strategic partners
Low operational costs to produce high-quality product
License to sell received in June 2017
Partnerships for cannabis sales with Aurora Cannabis and Emerald Health Botanicals
First reported quarter of sales to be reported by end of 2017
Well-funded with over $70 million raised collectively in 2016 and 2017
2016 private placement of $55 million from a syndicate of four banks led by Canaccord Genuity Corp
7ACRES property with 342,000 square-foot hybrid greenhouse facility
Expecting to run at full capacity in 2019 producing 50,000 kg per annum
Strong management team with notable experience in the cannabis space
More
https://investingnews.com/company-profiles/cannabis-wholesale-commercial-scale-producing-craft-quality-7acres/
$SPRWF 1.58 Supreme Pharmaceutical News Friday 11/24/17 #cannabis
SUPREME SIGNS HIGH-QUALITY FLOWER SUPPLY LOI AGREEMENT WITH ABLE BC.
http://www.supreme.ca/news/press-release-details/2017/Supreme-signs-High-Quality-Flower-supply-LOI-agreement-with-ABLE-BC/default.aspx
The Alliance of Beverage Licensees (ABLE BC)
https://ablebc.ca
B.C.’s liquor stores are the responsible way to retail #cannabis $SPRWF
http://vancouversun.com/opinion/op-ed/opinion-b-c-s-liquor-stores-are-the-responsible-way-to-retail-cannabis
Website: Supreme Pharmaceuticals
http://www.supreme.ca/investors/overview/default.aspx
Filings: on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
https://twitter.com/supremepharma
Supreme Pharmaceuticals Inc—Producing Craft Quality Cannabis at Commercial Scale
Overview
Supreme Pharmaceuticals Inc (TSXV:FIRE) is a licensed producer uniquely implementing B2B cannabis sales within Canada. Based in Ontario, the company is headed in Toronto and their sole asset, 7ACRES, is situated in Kincardine, on the southern shores of Lake Huron. Supreme Pharmaceuticals’ mission is to lead the cannabis industry, innovate and keep pushing cannabis forward while remaining focused on the quality of the product.
The first to adopt a licensed B2B wholesale model in Canada, Supreme Pharmaceuticals’ approach is based on producing high-quality cannabis that can be sold at a commercial scale to licensed producers, value-add manufacturers, storefronts and more. The goal of this approach is to allow for specialization across the industry, allowing partners to develop and succeed while they are supplied with quality cannabis.
To this effect, once they obtained their license to sell from their 7ACRES property in June 2017, Supreme Pharmaceutical entered into sale partnerships in September with two licensed producers, Aurora Cannabis (TSXV:ACB) and Emerald Health Botanicals, a subsidiary of Emerald Health Therapeutics (TSXV:EMH).
The 7ACRES property is on its way to becoming the country’s leading producer of high-quality commercial cannabis at a scale that has not yet been seen. Currently cultivating on 16,500 square feet, Supreme expects to have the entire 342,000-square-foot hybrid greenhouse facility running at full capacity by 2019 with a projected 50,000 kilograms of cannabis produced per year and $200 million to $400 million in revenue per year.
Supreme’s management team is one with vast amounts of experience in the cannabis and financial sectors. The team is headed by John Fowler, a lawyer that has been an advocate for the cannabis industry and thus has deep knowledge of both the medicinal and recreational spaces.
Investment Highlights
Innovative wholesale business model for bulk cannabis sales to strategic partners
Low operational costs to produce high-quality product
License to sell received in June 2017
Partnerships for cannabis sales with Aurora Cannabis and Emerald Health Botanicals
First reported quarter of sales to be reported by end of 2017
Well-funded with over $70 million raised collectively in 2016 and 2017
2016 private placement of $55 million from a syndicate of four banks led by Canaccord Genuity Corp
7ACRES property with 342,000 square-foot hybrid greenhouse facility
Expecting to run at full capacity in 2019 producing 50,000 kg per annum
Strong management team with notable experience in the cannabis space
More
https://investingnews.com/company-profiles/cannabis-wholesale-commercial-scale-producing-craft-quality-7acres/
Friday's News 11/24/17 on $FIRE $SPRWF...link
http://www.supreme.ca/news/press-release-details/2017/Supreme-signs-High-Quality-Flower-supply-LOI-agreement-with-ABLE-BC/default.aspx
$SPRWF..SLOWMO: More joyous #Wappa buds from @7AcresMJ and @SupremePharma. Hand polished and ready to smoke! #Cannabis $FIRE.CA
https://twitter.com/MidasLetter/status/934478413556981760
B.C.’s liquor stores are the responsible way to retail #cannabis $SPRWF
http://vancouversun.com/opinion/op-ed/opinion-b-c-s-liquor-stores-are-the-responsible-way-to-retail-cannabis
Supreme Pharmaceuticals
http://www.supreme.ca/news/press-release-details/2017/Supreme-signs-High-Quality-Flower-supply-LOI-agreement-with-ABLE
The Alliance of Beverage Licensees (ABLE BC)
https://ablebc.ca
$SPRWF..B.C.’s liquor stores are the responsible way to retail cannabis
http://vancouversun.com/opinion/op-ed/opinion-b-c-s-liquor-stores-are-the-responsible-way-to-retail-cannabis
https://ablebc.ca
$SPRWF 1.34..SUPREME SIGNS HIGH-QUALITY FLOWER SUPPLY LOI AGREEMENT WITH ABLE BC.
http://www.supreme.ca/news/press-release-details/2017/Supreme-signs-High-Quality-Flower-supply-LOI-agreement-with-ABLE
Supreme Pharmaceuticals Inc.
Website
http://www.supreme.ca/investors/overview/default.aspx
Filings on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
https://twitter.com/supremepharma
Pilbara Minerals $PILBF Nov 23, 2017 Announcements/Presentation...
http://www.pilbaraminerals.com.au/site/investors-media/reports-and-announcements/ASX-Announcements
$MPXEF 0.413 #MJ Ohio Receives 370 Applications for up to 60 Medical Cannabis Dispensary Licenses
November 20, 2017 at 3:52 pm
The State of Ohio Board of Pharmacy announced that it received 370 dispensary applications by the deadline on November 17th. The agency is authorized to award up to 60 licenses as part of the process it described in September. The complete list of applicants was posted to the Ohio Medical Marijuana Control Program website.
The applicants include at least two publicly-traded companies, with Liberty Health Sciences (CSE: LHS) (OTC: LHSIF) and MPX Bioceutical (CSE: MPX) (OTC: MPXEF) each submitting multiple applications. The entity for Liberty, Schottenstein Aphria III LLC, submitted four applications. The entity for MPX, GreenMart, submitted three applications.
Several well known multi-state operators also applied, including Columbia Care (3), Cresco Labs (5), GTI (12), Harvest (10) and PharmaCann (6) all submitting multiple applications. Andy Joseph, the founder of Apeks Supercritical, submitted 5 applications under the Ohio Grown Therapies banner.
https://www.newcannabisventures.com/ohio-receives-370-applications-for-up-to-60-medical-cannabis-dispensary-licenses/
MPX Bioceutical Corporation
https://www.otcmarkets.com/stock/MPXEF/profile
http://canadianbioceutical.com/wp-content/uploads/Management-Presentation_27-October-2017-web.pdf
Recent news
Name Change to MPX Bioceutical Corporation..and more
https://www.otcmarkets.com/stock/MPXEF/news
$MPXEF 0.413 Ohio Receives 370 Applications for up to 60 Medical Cannabis Dispensary Licenses
November 20, 2017 at 3:52 pm
The State of Ohio Board of Pharmacy announced that it received 370 dispensary applications by the deadline on November 17th. The agency is authorized to award up to 60 licenses as part of the process it described in September. The complete list of applicants was posted to the Ohio Medical Marijuana Control Program website.
The applicants include at least two publicly-traded companies, with Liberty Health Sciences (CSE: LHS) (OTC: LHSIF) and MPX Bioceutical (CSE: MPX) (OTC: MPXEF) each submitting multiple applications. The entity for Liberty, Schottenstein Aphria III LLC, submitted four applications. The entity for MPX, GreenMart, submitted three applications.
Several well known multi-state operators also applied, including Columbia Care (3), Cresco Labs (5), GTI (12), Harvest (10) and PharmaCann (6) all submitting multiple applications. Andy Joseph, the founder of Apeks Supercritical, submitted 5 applications under the Ohio Grown Therapies banner.
https://www.newcannabisventures.com/ohio-receives-370-applications-for-up-to-60-medical-cannabis-dispensary-licenses/
MPX Bioceutical Corporation
https://www.otcmarkets.com/stock/MPXEF/profile
http://canadianbioceutical.com/wp-content/uploads/Management-Presentation_27-October-2017-web.pdf
Recent news
Name Change to MPX Bioceutical Corporation..and more
https://www.otcmarkets.com/stock/MPXEF/news
$MPXEF 0.413 Ohio Receives 370 Applications for up to 60 Medical Cannabis Dispensary Licenses
November 20, 2017 at 3:52 pm
The State of Ohio Board of Pharmacy announced that it received 370 dispensary applications by the deadline on November 17th. The agency is authorized to award up to 60 licenses as part of the process it described in September. The complete list of applicants was posted to the Ohio Medical Marijuana Control Program website.
The applicants include at least two publicly-traded companies, with Liberty Health Sciences (CSE: LHS) (OTC: LHSIF) and MPX Bioceutical (CSE: MPX) (OTC: MPXEF) each submitting multiple applications. The entity for Liberty, Schottenstein Aphria III LLC, submitted four applications. The entity for MPX, GreenMart, submitted three applications.
Several well known multi-state operators also applied, including Columbia Care (3), Cresco Labs (5), GTI (12), Harvest (10) and PharmaCann (6) all submitting multiple applications. Andy Joseph, the founder of Apeks Supercritical, submitted 5 applications under the Ohio Grown Therapies banner.
https://www.newcannabisventures.com/ohio-receives-370-applications-for-up-to-60-medical-cannabis-dispensary-licenses/
MPX Bioceutical Corporation
https://www.otcmarkets.com/stock/MPXEF/profile
http://canadianbioceutical.com/wp-content/uploads/Management-Presentation_27-October-2017-web.pdf
Recent news
Name Change to MPX Bioceutical Corporation..and more
https://www.otcmarkets.com/stock/MPXEF/news
$STCC 3rd Q Results of Operations (small float)..Sterling Consolidated Corp., through its subsidiary, Sterling Seal and Supply Inc., distributes and sells O-rings and other rubber products worldwide. The company provides O-rings, rubber seals, oil seals, custom molded rubber parts, custom Teflon parts, Teflon rods, O-ring cords, bonded seals, O-ring kits, and stuffing box sealant products for use in automotive, pump, transmission, oil and energy, machinery, and packaging industries. It serves smaller distributors and original equipment manufacturers. The company, through its other subsidiaries, offers freight forwarding and related services; and rents commercial space to third parties.
Outstanding Shares 41,429,040 a/o Nov 01, 2017
Float 5,750,333 a/o Mar 04, 2015
Results of Operations
Comparison for the three months ended September 30, 2017 and 2016
Net Revenue
Net revenue increased by approximately $202,701 or approximately 14.6%, from $1,384,248 for the three months ended September 30, 2016 to $ 1,586,949 for the three months ended September 30, 2017. This increase was due primarily to increased demand from the industrial sector.
Total Cost of Sales
Cost of sales increased by $485,274 or approximately 15%, from $3,136,832 for the nine months ended September 30, 2016 to $3,622,106 for the nine months ended September 30, 2017. The increase in cost of sales was attributed to a commensurate increase in sales.
Gross profit
Gross profit decreased by $93,718 or approximately 20.2%, from $ 463,934 for the three months ended September 30, 2016 to $370,216 for the three months ended September 30, 2017. This decrease was due primarily to the above described increase in higher labor due to increased warehouse headcount in the current quarter.
Net Income
As a result of the above factors, the Company showed a net income of $83,161 for the three months ended September 30, 2017, as compared to a net loss of $13,888 for the three months ended September 30, 2016. This increase of $97,049or approximately 699% is primarily attributed to the above described increase in sales coupled with an increase in other income of $99,694 composed of a write-off of a vendor payable of $78,973 plus a refund on a copier lease of $20,547. Additionally, general and administrative costs decreased by $30,449 over the same period which was primarily attributed to a decrease of $21,431 in legal and accounting costs coupled with a decrease of approximately $17,000 in payroll due to decreased administrative headcount.
Comparison for the nine months ended September 30, 2017 and 2016
Revenue
Revenue increased by approximately $517,278 or approximately 12%, from $4,422,717 for the nine months ended September 30, 2016 to $4,939,995 for the nine months ended September 30, 2017. This increase is due to increased demand for o-rings in the industrial sector.
Total Cost of Sales
Cost of sales increased by $485,274 or approximately 15%, from $3,136,832 for the nine months ended September 30, 2016 to $3,622,106 for the nine months ended September 30, 2017. The increase in cost of sales was attributed to a commensurate increase in sales.
4
Gross profit
Gross profit increased by approximately $32,004 or approximately 2%, from $1,285,885 for the nine months ended September 30, 2016 to $1,317,889 for the nine months ended September 30, 2017. This increase can be attributed to the above described changes in revenue and cost of sales.
Net Loss
As a result of the above described changes in revenue and cost of sales, our net income was $157,662 for the nine months ended September 30, 2017, as compared to a net loss of $87,120 for the nine months ended September 30, 2016. This was an increase of $244,782 or approximately 281%. This increase can be explained by increased sales coupled with the previously described reduced general and administrative costs and increase of $99,521 increase in other income in the third quarter.
https://ih.advfn.com/p.php?pid=nmona&article=76134934
Sterling Consolidated Corp
https://www.otcmarkets.com/stock/STCC/profile
http://www.sterlingseal.com
http://www.sterlingconsolidated.com
AMAZON
https://www.amazon.com/s/ref=bl_dp_s_web_0?ie=UTF8&search-alias=aps&field-keywords=Sterling+Seal+%26+Supply
Oct. 2017 interview
https://upticknewswire.com/featured-interview-ceo-angelo-derosa-of-sterling-consolidated-corp-otcpink-stcc-2/
$STCC 3rd Q Results of Operations
Comparison for the three months ended September 30, 2017 and 2016
Net Revenue
Net revenue increased by approximately $202,701 or approximately 14.6%, from $1,384,248 for the three months ended September 30, 2016 to $ 1,586,949 for the three months ended September 30, 2017. This increase was due primarily to increased demand from the industrial sector.
Total Cost of Sales
Cost of sales increased by $485,274 or approximately 15%, from $3,136,832 for the nine months ended September 30, 2016 to $3,622,106 for the nine months ended September 30, 2017. The increase in cost of sales was attributed to a commensurate increase in sales.
Gross profit
Gross profit decreased by $93,718 or approximately 20.2%, from $ 463,934 for the three months ended September 30, 2016 to $370,216 for the three months ended September 30, 2017. This decrease was due primarily to the above described increase in higher labor due to increased warehouse headcount in the current quarter.
Net Income
As a result of the above factors, the Company showed a net income of $83,161 for the three months ended September 30, 2017, as compared to a net loss of $13,888 for the three months ended September 30, 2016. This increase of $97,049or approximately 699% is primarily attributed to the above described increase in sales coupled with an increase in other income of $99,694 composed of a write-off of a vendor payable of $78,973 plus a refund on a copier lease of $20,547. Additionally, general and administrative costs decreased by $30,449 over the same period which was primarily attributed to a decrease of $21,431 in legal and accounting costs coupled with a decrease of approximately $17,000 in payroll due to decreased administrative headcount.
Comparison for the nine months ended September 30, 2017 and 2016
Revenue
Revenue increased by approximately $517,278 or approximately 12%, from $4,422,717 for the nine months ended September 30, 2016 to $4,939,995 for the nine months ended September 30, 2017. This increase is due to increased demand for o-rings in the industrial sector.
Total Cost of Sales
Cost of sales increased by $485,274 or approximately 15%, from $3,136,832 for the nine months ended September 30, 2016 to $3,622,106 for the nine months ended September 30, 2017. The increase in cost of sales was attributed to a commensurate increase in sales.
4
Gross profit
Gross profit increased by approximately $32,004 or approximately 2%, from $1,285,885 for the nine months ended September 30, 2016 to $1,317,889 for the nine months ended September 30, 2017. This increase can be attributed to the above described changes in revenue and cost of sales.
Net Loss
As a result of the above described changes in revenue and cost of sales, our net income was $157,662 for the nine months ended September 30, 2017, as compared to a net loss of $87,120 for the nine months ended September 30, 2016. This was an increase of $244,782 or approximately 281%. This increase can be explained by increased sales coupled with the previously described reduced general and administrative costs and increase of $99,521 increase in other income in the third quarter.
https://ih.advfn.com/p.php?pid=nmona&article=76134934
Sterling Consolidated Corp
https://www.otcmarkets.com/stock/STCC/profile
http://www.sterlingseal.com
http://www.sterlingconsolidated.com
https://www.amazon.com/s/ref=bl_dp_s_web_0?ie=UTF8&search-alias=aps&field-keywords=Sterling+Seal+%26+Supply
Oct. 2017 interview
https://upticknewswire.com/featured-interview-ceo-angelo-derosa-of-sterling-consolidated-corp-otcpink-stcc-2/
$STCC 3rd Q Results of Operations
Comparison for the three months ended September 30, 2017 and 2016
Net Revenue
Net revenue increased by approximately $202,701 or approximately 14.6%, from $1,384,248 for the three months ended September 30, 2016 to $ 1,586,949 for the three months ended September 30, 2017. This increase was due primarily to increased demand from the industrial sector.
Total Cost of Sales
Cost of sales increased by $485,274 or approximately 15%, from $3,136,832 for the nine months ended September 30, 2016 to $3,622,106 for the nine months ended September 30, 2017. The increase in cost of sales was attributed to a commensurate increase in sales.
Gross profit
Gross profit decreased by $93,718 or approximately 20.2%, from $ 463,934 for the three months ended September 30, 2016 to $370,216 for the three months ended September 30, 2017. This decrease was due primarily to the above described increase in higher labor due to increased warehouse headcount in the current quarter.
Net Income
As a result of the above factors, the Company showed a net income of $83,161 for the three months ended September 30, 2017, as compared to a net loss of $13,888 for the three months ended September 30, 2016. This increase of $97,049or approximately 699% is primarily attributed to the above described increase in sales coupled with an increase in other income of $99,694 composed of a write-off of a vendor payable of $78,973 plus a refund on a copier lease of $20,547. Additionally, general and administrative costs decreased by $30,449 over the same period which was primarily attributed to a decrease of $21,431 in legal and accounting costs coupled with a decrease of approximately $17,000 in payroll due to decreased administrative headcount.
Comparison for the nine months ended September 30, 2017 and 2016
Revenue
Revenue increased by approximately $517,278 or approximately 12%, from $4,422,717 for the nine months ended September 30, 2016 to $4,939,995 for the nine months ended September 30, 2017. This increase is due to increased demand for o-rings in the industrial sector.
Total Cost of Sales
Cost of sales increased by $485,274 or approximately 15%, from $3,136,832 for the nine months ended September 30, 2016 to $3,622,106 for the nine months ended September 30, 2017. The increase in cost of sales was attributed to a commensurate increase in sales.
4
Gross profit
Gross profit increased by approximately $32,004 or approximately 2%, from $1,285,885 for the nine months ended September 30, 2016 to $1,317,889 for the nine months ended September 30, 2017. This increase can be attributed to the above described changes in revenue and cost of sales.
Net Loss
As a result of the above described changes in revenue and cost of sales, our net income was $157,662 for the nine months ended September 30, 2017, as compared to a net loss of $87,120 for the nine months ended September 30, 2016. This was an increase of $244,782 or approximately 281%. This increase can be explained by increased sales coupled with the previously described reduced general and administrative costs and increase of $99,521 increase in other income in the third quarter.
https://ih.advfn.com/p.php?pid=nmona&article=76134934
Sterling Consolidated Corp
https://www.otcmarkets.com/stock/STCC/profile
http://www.sterlingseal.com
http://www.sterlingconsolidated.com
https://www.amazon.com/s/ref=bl_dp_s_web_0?ie=UTF8&search-alias=aps&field-keywords=Sterling+Seal+%26+Supply
$CCNI 0.505 3rd Quarter report and announced uplisting to major exchange.
Command Center Inc. Temporary staffing #jobs
http://www.commandonline.com
http://stockcharts.com/h-sc/ui?s=CCNI
Q3 2017 PR
http://www.irdirect.net/CCNI/corporate_overview?title_override=Recent%20News
SEC filing Q3 2017
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12377138
Conference call replay
http://public.viavid.com/player/index.php?id=127199
CC transcript
https://seekingalpha.com/article/4124838-command-centers-ccni-ceo-bubba-sandford-q3-2017-results-earnings-call-transcript
Latest Presentation Sept. 2017
http://www.irdirect.net/CCNI/corporate_documents?type=1004&template=dms_years_pagination&hide_years_pagination=1&hide_title=1&title_override=Investor%20Presentation
OTCmarkets profile..Command Center, Inc.
CCNI Security Details
Share Structure
Market Value1 $29,701,619 a/o Nov 17, 2017
Authorized Shares 100,000,000 a/o Nov 17, 2017
Outstanding Shares 60,615,549 a/o Nov 17, 2017
-Restricted 8,290,396 a/o Nov 17, 2017
-Unrestricted 52,325,153 a/o Nov 17, 2017
Held at DTC 42,685,593 a/o Nov 17, 2017
Float 44,944,576 a/o Dec 30, 2016
Par Value 0.001
https://www.otcmarkets.com/stock/CCNI/profile
$SPRWF 1.23 ^7% Supreme Pharmaceuticals’ (OTC: SPRWF) (TSXV: FIRE) wholly owned 7ACRES subsidiary recently received approval from Health Canada to begin cultivation at its 30,000 square-foot flowering rooms at the company's hybrid grow facility. The additional flowering rooms increases the size of 7ACRES' flowering facility to 40,000 square feet. 7ACRES, and thus Supreme, also has its footing in oils via a retail partnership with Aurora Cannabis (TSX: ACB) (OTC: ACBFF). In its fourth-quarter financial results, Aurora said sales of dried medical cannabis and cannabis oils contributed $5.6 million to revenues, of which $0.4 million (7.1%) was generated in Germany and $5.2 million in Canada (http://nnw.fm/MOgY2).
Adoption of cannabis oil continues to increase as a preferred alternative to cannabinoid consumption, providing cannabis cultivators with an unprecedented market opportunity paced by rising consumer demand.
https://www.networknewswire.com/rising-demand-cannabis-oils-pushes-canadas-producers-overdrive/
Supreme Commences Production in New Flowering Rooms
November 07, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Commences-Production-in-New-Flowering-Rooms/default.aspx
Supreme Crosses Important Revenue Milestone
October 03, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Crosses-Important-Revenue-Milestone/default.aspx
Supreme Completes First Sales with Aurora Cannabis
September 05, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Completes-First-Sales-with-Aurora-Cannabis-/default.aspx
more
http://www.supreme.ca/investors/overview/default.aspx
Filings on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
$SPRWF 1.23 ^7% Supreme Pharmaceuticals’ (OTC: SPRWF) (TSXV: FIRE) wholly owned 7ACRES subsidiary recently received approval from Health Canada to begin cultivation at its 30,000 square-foot flowering rooms at the company's hybrid grow facility. The additional flowering rooms increases the size of 7ACRES' flowering facility to 40,000 square feet. 7ACRES, and thus Supreme, also has its footing in oils via a retail partnership with Aurora Cannabis (TSX: ACB) (OTC: ACBFF). In its fourth-quarter financial results, Aurora said sales of dried medical cannabis and cannabis oils contributed $5.6 million to revenues, of which $0.4 million (7.1%) was generated in Germany and $5.2 million in Canada (http://nnw.fm/MOgY2).
Adoption of cannabis oil continues to increase as a preferred alternative to cannabinoid consumption, providing cannabis cultivators with an unprecedented market opportunity paced by rising consumer demand.
https://www.networknewswire.com/rising-demand-cannabis-oils-pushes-canadas-producers-overdrive/
Supreme Commences Production in New Flowering Rooms
November 07, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Commences-Production-in-New-Flowering-Rooms/default.aspx
Supreme Crosses Important Revenue Milestone
October 03, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Crosses-Important-Revenue-Milestone/default.aspx
Supreme Completes First Sales with Aurora Cannabis
September 05, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Completes-First-Sales-with-Aurora-Cannabis-/default.aspx
more
http://www.supreme.ca/investors/overview/default.aspx
Filings on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
$SPRWF 1.23 ^7% Supreme Pharmaceuticals’ (OTC: SPRWF) (TSXV: FIRE) wholly owned 7ACRES subsidiary recently received approval from Health Canada to begin cultivation at its 30,000 square-foot flowering rooms at the company's hybrid grow facility. The additional flowering rooms increases the size of 7ACRES' flowering facility to 40,000 square feet. 7ACRES, and thus Supreme, also has its footing in oils via a retail partnership with Aurora Cannabis (TSX: ACB) (OTC: ACBFF). In its fourth-quarter financial results, Aurora said sales of dried medical cannabis and cannabis oils contributed $5.6 million to revenues, of which $0.4 million (7.1%) was generated in Germany and $5.2 million in Canada (http://nnw.fm/MOgY2).
Adoption of cannabis oil continues to increase as a preferred alternative to cannabinoid consumption, providing cannabis cultivators with an unprecedented market opportunity paced by rising consumer demand.
https://www.networknewswire.com/rising-demand-cannabis-oils-pushes-canadas-producers-overdrive/
Supreme Commences Production in New Flowering Rooms
November 07, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Commences-Production-in-New-Flowering-Rooms/default.aspx
Supreme Crosses Important Revenue Milestone
October 03, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Crosses-Important-Revenue-Milestone/default.aspx
Supreme Completes First Sales with Aurora Cannabis
September 05, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Completes-First-Sales-with-Aurora-Cannabis-/default.aspx
more
http://www.supreme.ca/investors/overview/default.aspx
$GRWG Growgeneration Corp. Investor Presentation November 2017 #MJ
https://growgeneration.com/static/img/grwg-investor-presentation-2017-nov.pdf
http://www.growgeneration.com/
GRWG Security Details
Share Structure
Market Value1
$29,409,518
a/o Nov 16, 2017
Authorized Shares
100,000,000
a/o Nov 01, 2017
Outstanding Shares
16,338,621
a/o Nov 01, 2017
Float
12,153,621
a/o Sep 30, 2017
GRWG OTCQX U.S
https://www.otcmarkets.com/stock/GRWG/profile
$GRWG Growgeneration Corp. Investor Presentation November 2017
https://growgeneration.com/static/img/grwg-investor-presentation-2017-nov.pdf
http://www.growgeneration.com/
GRWG OTCQX U.S
https://www.otcmarkets.com/stock/GRWG/profile
$GRWG Growgeneration Corp. Investor Presentation November 2017
https://growgeneration.com/static/img/grwg-investor-presentation-2017-nov.pdf
http://www.growgeneration.com/
GRWG OTCQX U.S
https://www.otcmarkets.com/stock/GRWG/profile
$SPRWF 1.19 (TSXV $FIRE) Supreme Pharmaceuticals Inc...
Website
http://www.supreme.ca/investors/overview/default.aspx
Filings on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000
https://twitter.com/supremepharma
https://www.instagram.com/p/BbUe-0WhpHO/
https://www.nytimes.com/2017/11/04/world/canada/canada-marijuana-legal-justin-trudeau.html
https://www.newcannabisventures.com/7acres-books-more-than-1-5-million-cannabis-sales-in-september/
SMDM..Q2 EPS of $0.02 Revenue of $32.8M (+16.6% Y/Y)
https://seekingalpha.com/news/3311822-singing-machine-reports-q2-results
$CODA #2 on IBD Investor's Business Daily top 10 under $10
https://www.investors.com/product/top-rated-stocks-under-10/
$SPRWF 1.35 SUPREME COMMENCES PRODUCTION IN NEW FLOWERING ROOMS
NOVEMBER 07, 2017
TSXV: FIRE
TORONTO, Nov. 7, 2017 /CNW/ - Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (TSXV: FIRE) is pleased to announce 7ACRES has commenced production in the newly constructed flowering rooms recently approved by Health Canada. Yesterday, over 3,000 plants of a specially selected phenotype of cannabis called "Wappa" were hand-transplanted into the first of three 10,000 sq. ft. flowering rooms. Wappa was selected for the inaugural planting due to its favourable early-stage market feedback, growth characteristics and terpene content. The transplanting was completed in a single-day process, required to ensure the uniformity of the end product. The remaining 20,000 sq. ft. will be fully planted over the balance of November 2017, increasing 7ACRES' anticipated annual output capacity to over 5,000 kg per year.
One of three new 10,000 sq. ft. flowering rooms at the 7ACRES Hybrid Facility (CNW Group/Supreme Pharmaceuticals Inc.)
"Today marks an important growth milestone for 7ACRES as Canada's leading cultivation-focused Licensed Producer," said John Fowler, CEO of Supreme. "Adding an additional 30,000 sq. ft. of flowering rooms quadruples our production capacity and moves us closer to achieving our goal of growing premium quality cannabis flowers at scale. The additional output increases our ability to establish national strategic partnerships with Licensed Producers that are seeking to provide Canadian patients with premium cannabis. As well, the expansion also represents the next step in scaling 7ACRES in preparation for the Canadian adult use market."
Supreme anticipates the first harvests from the additional flowering rooms will be completed in the first quarter of calandar 2018.
Licensed Producers and/or ACMPR applicants interested in procuring premium quality dried cannabis flowers or trim may contact wholesale@7ACRES.com.
About Supreme
Supreme is a Canadian publicly traded company established as the leading premium cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. hybrid-facility. This facility combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit supreme.ca and 7ACRES.com for more information.
http://www.supreme.ca/news/press-release-details/2017/Supreme-Commences-Production-in-New-Flowering-Rooms/default.aspx
$SMDM Singing Machine Announces Second Quarter
Net sales increased by 17% to $32.8 million for the September 30, 2017 quarter.
Gross profit for the second quarter increased to $7.7 million compared to $6.5 million in the prior year.
Gross margin increased by .5% to 23.6%.
A $2.0 million bad debt reserve was taken as a result of the Toys 'R' Us bankruptcy.
The Company reported income before tax of $1.2 million for the quarter.
Earnings per share of $0.02 per share on a fully diluted basis.
https://seekingalpha.com/pr/17001066-singing-machine-announces-second-quarter-2018-earnings-report
https://singingmachine.com
$PILBF Pilbara eyeing downstream processing #Lithium developer Pilbara Minerals has signed a nonbinding memorandum of understanding (MoU) to potentially develop a downstream lithium chemical conversion facility in South Korea.
The ASX-listed company on Friday noted that the MoU with Polaris Shipping and LG Chem would see Pilbara supply up to 30 000 t of lithium hydroxide to the South Korean lithium-ion battery industry.
MD and CEO Ken Brinsden told shareholders that the MoU represented an opportunity for Pilbara’s participation in one of the world’s most exciting and fastest growing markets for lithium raw materials outside of China.
“South Korea is a major global economic and industrial power with very large and rapidly growing high-technology industrial complex and automotive industry. Discussions like these represent an opportunity to work alongside two of South Korea’s leading conglomerates to participate in the development of a world-leading downstream lithium chemicals facility servicing the rapidly growing lithium-ion battery industry in South Korea.”
Brinsden said that these discussions were consistent with Pilbara’s broader objective to participate in downstream chemical facilities where it made sense for the company as an upstream supplier of spodumene concentrate, and to diversify Pilbara’s global sales arrangements.
“Given the scale of the existing resource and reserve at Pilgangoora, and the potential to continue to grow it with ongoing drilling, we have plenty of capacity to support both our existing customers in China and new customers elsewhere. Its fair to say that Korean lithium raw material demand is now well and truly on the radar.”
The Pilgangoora project is expected to produce an average of 314 000 t/y of 6% spodumene concentrate and 321 000 lb/y of tantalite, over a mine life of 36 years.
http://www.engineeringnews.co.za/article/pilbara-eyeing-downstream-processing-2017-11-10
More news links
http://www.engineeringnews.co.za/topic/ken-brinsden
http://www.pilbaraminerals.com.au/site/investors-media/reports-and-announcements/ASX-Announcements
http://www.pilbaraminerals.com.au/site/investors-media/news-highlights
$PILBF 0.805 Pilbara Minerals Ltd (ASX: $PLS) share price has continued its strong run and is up 5% to $1.03. This morning the lithium miner announced that it has signed a memorandum of understanding with Polaris Shipping to discuss a potential joint venture for a downstream lithium chemical conversion facility servicing South Korea’s rapidly growing lithium-ion battery industry.
https://www.fool.com.au/2017/11/10/why-these-4-asx-shares-are-ending-the-week-with-solid-gains-3/
S. Korean-led consortium to build lithium factory in Saemangeum
2017/11/09 16:57
SEJONG, Nov. 9 (Yonhap) -- A South Korean-led consortium will build a lithium production line in Saemanguem industrial complex on the western coast that will start production in 2020, a provincial development authority said Thursday.
A joint venture of three companies -- South Korean battery maker LG Chem, local ore carrier Polaris Shipping Co. and Australian miner Pilbara Minerals Ltd., -- will foot the investment bill of 345 billion won (US$309.2 million), the Saemangeum Development and Investment Agency said after signing a memorandum of understanding.
Work on the plant for the new venture, Lithium Korea, will begin in April 2018, with a goal of producing 30,000 tons of lithium annually starting in January 2020. That is enough to supply lithium for 50,000 electric vehicles, the agency said.
Polaris Shipping will deliver spodumene concentrate, a key ingredient for lithium production, from Pilabara Minerals' facility to nearby Gunsan port. The production line is also close to LG Chem's factories in the area, the agency said.
"It is important to secure raw materials to produce lithium," the Saemangeum agency said in a release. "The factory will be able to produce lithium stably, as a raw material supplier is joining the project."
South Korea imported 25,000 tons of lithium last year. Burdens on lithium battery makers have been rising as the price of lithium has skyrocketed 186.9 percent over the past two years.
The Saemangeum area in North Jeolla Province spans 40,200 hectares and is home to the world's longest seawall at 33.9 kilometers. The seawall construction was completed in 2010 to attract businesses in a variety of fields, including agriculture and renewable energy.
http://english.yonhapnews.co.kr/news/2017/11/09/0200000000AEN20171109010000320.html
http://www.pilbaraminerals.com.au/site/investors-media/news-highlights
$PILBF 0.805 Pilbara Minerals Ltd (ASX: $PLS) share price has continued its strong run and is up 5% to $1.03. This morning the lithium miner announced that it has signed a memorandum of understanding with Polaris Shipping to discuss a potential joint venture for a downstream lithium chemical conversion facility servicing South Korea’s rapidly growing lithium-ion battery industry.
https://www.fool.com.au/2017/11/10/why-these-4-asx-shares-are-ending-the-week-with-solid-gains-3/
S. Korean-led consortium to build lithium factory in Saemangeum
2017/11/09 16:57
SEJONG, Nov. 9 (Yonhap) -- A South Korean-led consortium will build a lithium production line in Saemanguem industrial complex on the western coast that will start production in 2020, a provincial development authority said Thursday.
A joint venture of three companies -- South Korean battery maker LG Chem, local ore carrier Polaris Shipping Co. and Australian miner Pilbara Minerals Ltd., -- will foot the investment bill of 345 billion won (US$309.2 million), the Saemangeum Development and Investment Agency said after signing a memorandum of understanding.
Work on the plant for the new venture, Lithium Korea, will begin in April 2018, with a goal of producing 30,000 tons of lithium annually starting in January 2020. That is enough to supply lithium for 50,000 electric vehicles, the agency said.
Polaris Shipping will deliver spodumene concentrate, a key ingredient for lithium production, from Pilabara Minerals' facility to nearby Gunsan port. The production line is also close to LG Chem's factories in the area, the agency said.
"It is important to secure raw materials to produce lithium," the Saemangeum agency said in a release. "The factory will be able to produce lithium stably, as a raw material supplier is joining the project."
South Korea imported 25,000 tons of lithium last year. Burdens on lithium battery makers have been rising as the price of lithium has skyrocketed 186.9 percent over the past two years.
The Saemangeum area in North Jeolla Province spans 40,200 hectares and is home to the world's longest seawall at 33.9 kilometers. The seawall construction was completed in 2010 to attract businesses in a variety of fields, including agriculture and renewable energy.
http://english.yonhapnews.co.kr/news/2017/11/09/0200000000AEN20171109010000320.html
http://www.pilbaraminerals.com.au/site/investors-media/news-highlights
$PILBF 0.805 Pilbara Minerals Ltd (ASX: $PLS) share price has continued its strong run and is up 5% to $1.03. This morning the lithium miner announced that it has signed a memorandum of understanding with Polaris Shipping to discuss a potential joint venture for a downstream lithium chemical conversion facility servicing South Korea’s rapidly growing lithium-ion battery industry.
https://www.fool.com.au/2017/11/10/why-these-4-asx-shares-are-ending-the-week-with-solid-gains-3/
S. Korean-led consortium to build lithium factory in Saemangeum
2017/11/09 16:57
SEJONG, Nov. 9 (Yonhap) -- A South Korean-led consortium will build a lithium production line in Saemanguem industrial complex on the western coast that will start production in 2020, a provincial development authority said Thursday.
A joint venture of three companies -- South Korean battery maker LG Chem, local ore carrier Polaris Shipping Co. and Australian miner Pilbara Minerals Ltd., -- will foot the investment bill of 345 billion won (US$309.2 million), the Saemangeum Development and Investment Agency said after signing a memorandum of understanding.
Work on the plant for the new venture, Lithium Korea, will begin in April 2018, with a goal of producing 30,000 tons of lithium annually starting in January 2020. That is enough to supply lithium for 50,000 electric vehicles, the agency said.
Polaris Shipping will deliver spodumene concentrate, a key ingredient for lithium production, from Pilabara Minerals' facility to nearby Gunsan port. The production line is also close to LG Chem's factories in the area, the agency said.
"It is important to secure raw materials to produce lithium," the Saemangeum agency said in a release. "The factory will be able to produce lithium stably, as a raw material supplier is joining the project."
South Korea imported 25,000 tons of lithium last year. Burdens on lithium battery makers have been rising as the price of lithium has skyrocketed 186.9 percent over the past two years.
The Saemangeum area in North Jeolla Province spans 40,200 hectares and is home to the world's longest seawall at 33.9 kilometers. The seawall construction was completed in 2010 to attract businesses in a variety of fields, including agriculture and renewable energy.
http://english.yonhapnews.co.kr/news/2017/11/09/0200000000AEN20171109010000320.html
http://www.pilbaraminerals.com.au/site/investors-media/news-highlights
$BOOT 12.17 Boot barn holdings, inc. announces second quarter fiscal year 2018 financial results; raises fiscal year 2018 outlook
http://investor.bootbarn.com/investor-relations/investor-news/news-details/2017/Boot-Barn-Holdings-Inc-Announces-Second-Quarter-Fiscal-Year-2018-Financial-Results-Raises-Fiscal-Year-2018-Outlook/default.aspx
$BOOT 12.17 Boot barn holdings, inc. announces second quarter fiscal year 2018 financial results; raises fiscal year 2018 outlook
http://investor.bootbarn.com/investor-relations/investor-news/news-details/2017/Boot-Barn-Holdings-Inc-Announces-Second-Quarter-Fiscal-Year-2018-Financial-Results-Raises-Fiscal-Year-2018-Outlook/default.aspx
Complete 10Q
As of November 2, 2017, the registrant had 26,667,221 shares of common stock outstanding, $0.0001 par value.
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12360825
Boot Barn Holdings, Inc. Second Quarter Fiscal Year 2018 Conference Call
November 2, 2017
http://investor.bootbarn.com/investor-relations/events-and-presentations/default.aspx
November 7, 2017
BOOT Investor Presentation
http://s2.q4cdn.com/167849013/files/doc_presentations/2017/Boot-Barn-Investor-Presentation-November-2017.pdf
$BOOT 12.17 Boot barn holdings, inc. announces second quarter fiscal year 2018 financial results; raises fiscal year 2018 outlook
http://investor.bootbarn.com/investor-relations/investor-news/news-details/2017/Boot-Barn-Holdings-Inc-Announces-Second-Quarter-Fiscal-Year-2018-Financial-Results-Raises-Fiscal-Year-2018-Outlook/default.aspx
Complete 10Q
As of November 2, 2017, the registrant had 26,667,221 shares of common stock outstanding, $0.0001 par value.
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12360825
Boot Barn Holdings, Inc. Second Quarter Fiscal Year 2018 Conference Call
November 2, 2017
http://investor.bootbarn.com/investor-relations/events-and-presentations/default.aspx
November 7, 2017
BOOT Investor Presentation
http://s2.q4cdn.com/167849013/files/doc_presentations/2017/Boot-Barn-Investor-Presentation-November-2017.pdf
$GRWG GrowGeneration Reports Record 3rd Quarter Revenue
PRESS RELEASE PR Newswire
Nov. 8, 2017, 08:30 AM
DENVER, Nov. 8, 2017 /PRNewswire/ -- GrowGeneration Corp. (OTCQX: GRWG), ("GrowGen" or the "Company") one of the largest specialty retail hydroponic and organic gardening stores, selling to both the commercial and home cannabis markets, with currently 14 locations, today reported financial results for its 3rd quarter ended September 30, 2017.
3rd Quarter 2017 Financial Highlights:
Revenue of $4.0 million, up 86% compared to revenue of $2.2 million for the 3rd quarter of 2016
For the 9 months ended September 30,2017, revenue totaled $10.7 million versus $5.6 million for the same 9 months ending 2016, an increase of 91%
Same-Store Sales increased 31% from $2.1 million for the 3rd quarter of 2016 compared to $2.7 million for the 3rd quarter of 2017
Adjusted EBITDA for the quarter ended September 30, 2017 totaled $(191,497) compared to adjusted EBITDA of $29,386 for the quarter ended September 30, 2016
Net loss of $460,887, inclusive of $265,971 in non-cash depreciation and share-based compensation expense, compared to a net income of $10,844 in the 3rd quarter of 2016, inclusive of $17,158 in non-cash depreciation expense.
The Company had $1.9 million in cash as of September 30, 2017
As of September 30, 2017, the Company had $8.2 million in total current assets compared with $3.6 million as of December 31, 2016.
The Company raised $4.8 million in equity capital for the 9 month period ended September 30, 2017 through the issuance of common stock and the exercise of warrants.
http://markets.businessinsider.com/news/stocks/GrowGeneration-Reports-Record-3rd-Quarter-Revenue-1007292167
Complete 10Q for 3rd Quarter 2017
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12369289
GRWG Security Details
Share Structure
Market Value1 $30,389,835 a/o Nov 08, 2017
Authorized Shares 100,000,000 a/o Nov 01, 2017
Outstanding Shares 16,338,621 a/o Nov 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 12,153,621 a/o Sep 30, 2017
Par Value 0.001
https://www.otcmarkets.com/stock/GRWG/profile
Website
https://growgeneration.com
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads